Bloomberg BNA, June 12, 2017. De novo is a way to get products to market without going through the FDA’s most stringent review process, premarket approval.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA Questions Effect of Abuse-Deterrent Opioids
Behavioral Healthcare Executive, June 13, 2017. FDA aims to gather information to determine the effects of products with abuse-deterring formulations.
Read More »Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety
Drugwatch, May 8, 2017. “Taxpayers are also paying for agency [funding], but we’re not treated as the customers — the companies are,” Zuckerman said.
Read More »Amy Reed, MD, Morcellator Opponent, Dies of Uterine Cancer
Medscape, May 25, 2017. Amy Reed, MD, Morcellator Opponent, Dies of Uterine Cancer.
Read More »Trump budget would cut $636 billion from HHS agencies
Modern Healthcare, May 22, 2017. President Donald Trump is proposing a $636 billion cut in federal funding for CMS programs over the next decade.
Read More »